ATTENTION ALL CUSTOMERS:
Due to a recent change in our pharmacy software system, the process for submitting refill requests online has now changed.
Our previous mobile app and your current login credentials will no longer work.
Please click the Refill Prescriptions tab to begin the new process.
Thank you for your patience during this transition.

Get Healthy!

Results for search "Drug Approvals".

Health News Results - 13

Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial

Another experimental drug meant to slow the damage of Alzheimer's appears poised to join a growing arsenal of new treatments for this memory-robbing disease.

In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer's A...

FDA Gives Full Approval to Alzheimer's Drug Leqembi

The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer's drug Leqembi, clearing the way for insurance coverage of the pricey drug.

"The full FDA approval will open the floodgates for people with early Alzheimer's to get this drug. It's a big deal because it's very expensive at $26,500 per year,"

  • Robin Foster HealthDay Reporter
  • |
  • July 6, 2023
  • |
  • Full Page
    • FDA Approves New Drugs to Treat Type 2 Diabetes in Kids

    The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.

    The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provide a new class of medications for pediatric type 2 diabetes. They join metformin, which has been approved for children wi...

    FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease

    Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).

    Rinvoq is meant to treat adults with moderately to severely active Crohn's disease who have not had success with TNF (tumor necrosis factor) blockers. The daily pill is the first oral treatment for this group of patients.

    Crohn's is ...

    FDA Approves First Drug Meant to Ease Alzheimer's-Linked Agitation

    A medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.

    The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approved treatment for these symptoms.

    "Agitation is one of the most common and challenging aspec...

    Experimental Alzheimer's Drug Slows Decline in Thinking in Late-Stage Trial

    Another experimental drug meant for Alzheimer's disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.

    Known as donanemab, the medication clears amyloid plaque from the brain. In a late trial, the drug slowed memory and thinking declines in early symptomatic Alzheimer's patients by more than a third, Li...

    Could a Vibrating Pill Ease Chronic Constipation?

    A new treatment for chronic constipation may bring relief without having to use drugs.

    It's a vibrating pill called Vibrant that stimulates the colon as it passes through the body.

    Although the pill was

  • Cara Murez HealthDay Reporter
  • |
  • February 9, 2023
  • |
  • Full Page
    • FDA Approves New 2-Drug Combo Medicine for Asthma

    Adults with asthma now have a new rescue medication to turn to after the U.S. Food and Drug Administration approved Airsupra on Wednesday.

    The drug is the first approved to combine albuterol (a beta-2 adrenergic agonist) and budesonide (a corticosteroid).

    It's mea...

    First FDA-Approved Fecal-Based Treatment Helps Fight a Tough Superbug

    The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.

    "Today's approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI]," said

  • Cara Murez HealthDay Reporter
  • |
  • December 1, 2022
  • |
  • Full Page
    • A Gene Therapy for Hemophilia That Costs $3.5 Million Gets FDA Approval

    People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag.

    The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed its cost.

    The company said its drug would ultimately reduce health care costs because patients with the genetic disorder would ne...

    FDA Approves New ALS Drug Despite Uncertain Data

    The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease.

    But appro...

    Hints That Experimental Drug Might Curb a Form of ALS

    People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows.

    The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leads to amyotrophic lateral sclerosis, also kn...

    Merck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDA

    Merck's experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration.

    On Friday morning Merck announced

  • Robert Preidt and Robin Foster
  • |
  • November 29, 2021
  • |
  • Full Page